Medline Inc. earnings releases MDLN

Annual Quarterly

Medline Inc. last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 26, 2026): revenue of $7.9 billion and diluted EPS of $0.22. It usually reports 39–56 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 24, 2027.

Next earnings release

~Feb 24, 2027

Estimated

Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 25, 2026. This is an estimate, not a date the company has announced.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 39–56 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Nov 4, 2026 39 days after quarter end	Q3 FY2026 ended Sep 26, 2026	7,856	318	0.22
Aug 5, 2026 39 days after quarter end	Q2 FY2026 ended Jun 27, 2026	7,685	139	0.07
May 6, 2026 39 days after quarter end	Q1 FY2026 ended Mar 28, 2026	7,352	239	0.16
Feb 25, 2026 56 days after quarter end	— ended Dec 31, 2025	—	—	—

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: MDLN (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Northfield, IL
SEC filer status: Non-accelerated filer
SEC CIK: 2046386

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.